Director at TransMedics (TMDX) receives 2,922 RSUs, lifting holdings to 15,056 shares

Rhea-AI Filing Summary

Weill David reported acquisition or exercise transactions in this Form 4 filing.

TransMedics Group, Inc. director David Weill reported an equity compensation grant of 2,922 shares of common stock in the form of restricted stock units. Each RSU represents a contingent right to receive one share of common stock, with no cash paid per share. Following this award, Weill directly holds 15,056 shares of TransMedics common stock, reflecting a routine compensation-related increase in his ownership rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Weill David

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,922	$0.00	--

Holdings After Transaction: Common Stock — 15,056 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant: 2,922 units Post-transaction holdings: 15,056 shares Grant price: $0.00 per share

3 metrics

RSU grant 2,922 units Restricted stock units awarded to director on 2026-05-20

Post-transaction holdings 15,056 shares Common stock directly owned by David Weill after grant

Grant price $0.00 per share Indicates equity award, not open-market purchase

Key Terms

restricted stock units, RSUs, contingent right

3 terms

restricted stock units financial

"Consists of 2,922 restricted stock units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Each RSU represents a contingent right to receive one share"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

contingent right financial

"Each RSU represents a contingent right to receive one share"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weill David

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MASSACHUSETTS 01810

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		2,922(1)	A	$0	15,056	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of 2,922 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	By: /s/ Gerardo Hernandez, Attorney-in-Fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TransMedics (TMDX) director David Weill report?

Director David Weill reported an equity award of 2,922 restricted stock units. These RSUs are a form of stock-based compensation that convert into common shares over time, increasing his direct stake in TransMedics without an open-market share purchase.

How many TransMedics (TMDX) shares does David Weill hold after this Form 4 filing?

After the reported RSU grant, David Weill directly holds 15,056 shares of TransMedics common stock. This total includes the 2,922 restricted stock units, which each represent a contingent right to receive one share upon satisfaction of applicable vesting conditions.

What does the 2,922 RSU grant mean for TransMedics (TMDX) director compensation?

The 2,922-unit grant reflects stock-based compensation for director David Weill. Each restricted stock unit converts into one TransMedics common share if vesting conditions are met, aligning his incentives with shareholders through additional equity rather than cash salary alone.

Did David Weill buy or sell TransMedics (TMDX) shares on the market in this Form 4?

This Form 4 shows an acquisition through a grant, not a market trade. The 2,922 shares were awarded as restricted stock units at a stated price of $0.00 per share, indicating compensation rather than an open-market purchase or sale.

What are restricted stock units (RSUs) in the TransMedics (TMDX) filing for David Weill?

Restricted stock units are promises to deliver shares in the future if conditions are met. In this filing, each of the 2,922 RSUs entitles David Weill to receive one TransMedics common share, typically after vesting under the company’s equity compensation arrangements.